ea0051p057 | Pituitary and growth | BSPED2017
Kanumakala Shankar
, Johnstone Helen
, Kumar Yadlapalli
, Heaton Josephine
, Zabransky Markus
Introduction: PATRO children is an international, non-interventional, longitudinal study of the long-term safety of a biosimilar recombinant human growth hormone (Omnitrope, Sandoz). In particular, the study assesses the diabetogenic potential of Omnitrope and the risk of malignancies. The long-term efficacy is a secondary objective of the study. Here we present safety and efficacy data of UK patients recruited since 2008, following an interim analysis in May 2017.<p class...